Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Evidence links the gut microbiota and fertility to women’s reproductive health, influencing hormone metabolism, and ...

IBD research, for all its sophistication, has been searching under the lamppost — sequencing, mapping and quantifying what can be seen. But the key may lie in the park, in the unseen intersections of ...

By electrically stimulating macrophages, scientists at Trinity College Dublin have found a way to calm inflammation and ...

Subject: Violation of Open Expression Policy in the Dismissal of Dr. Anna Kenney Dear Dr. Wong, Dr. Liebeskind, Dr. Lee and Justice Sears, We, the undersigned senior faculty members of Emory ...

A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the long-used medicine could be repurposed to combat MS in people with female ...

Nicholas Barnes owns shares and is a Director of Celentyx Ltd; a pharmecuetical R&D company that performs research aimed at identifying new and improved ways to treat diseses involving the immune ...

LIMA — Lima City Council will hold a special meeting at 6:30 p.m. Tuesday, Sept. 30 or following that day’s human resources meeting in the city building, 50 Town Square, Lima. The human resources ...

WINTER HAVEN, Fla. — Polk County Sheriff Grady Judd announced that 246 people were arrested in a seven-day, undercover operation dubbed "Fool around and Find Out - Again." The sheriff held a news ...

α-Syn (alpha-synuclein) increases and oligomerization contributes to ischemic brain damage. Nevertheless, the exact mechanisms of ischemia-induced α-Syn pathology after stroke are understudied. In ...

SAN DIEGO, CA / ACCESS Newswire / September 9, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing ...